IP Verse

Crispr-Based Genome Modification And Regulation

EP3360964

SIGMA-ALDRICH CO. LLC
Application Number
EP18156734A
Filing Date
Dec 5, 2013
Status
Granted And Under Opposition
Aug 30, 2019
Grant Date
Oct 2, 2019
External Links
Slate, Register

Biblio Summary

The patent EP3360964B1 was granted on Oct 2, 2019 by Sigma-Aldrich Co. Llc The patent is currently Granted And Under Opposition.

Oppositions Filed by other Companies on the Patent

The table below shows 8 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

MATHYS & SQUIRE LLPJul 2, 2020ADMISSIBLE
PATENTANWALTE ISENBRUCK BOSL HORSCHLER PARTG MBBJul 2, 2020ADMISSIBLE
SCHLICH, GEORGE WILLIAMJul 2, 2020ADMISSIBLE
BASF SEJul 1, 2020ADMISSIBLE
PATENT BOUTIQUE LLPMar 2, 2020ADMISSIBLE
GRUND, DR., MARTINFeb 4, 2020ADMISSIBLE
BAYER AG / BAYER INTELLECTUAL PROPERTY GMBHDec 23, 2019ADMISSIBLE
VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBBNov 22, 2019ADMISSIBLE

More Opposed Patents of Sigma-Aldrich Co. Llc

The table below shows the patents of Sigma-Aldrich Co. Llc that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP3363902Crispr-Based Genome Modification And RegulationNov 27, 20197
EP2928496Crispr-Based Genome Modification And RegulationOct 9, 20198
EP3138911Crispr-Based Genome Modification And RegulationDec 5, 20189

Dossier Documents of the Patent

The documents dossier of the patent at EPO including all essential records in the patent's lifecycle, from filing to grant to oppositions.

  • Date

    Description

  • Get instant alerts for new documents